Biotech News
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
ir.89bio.com2026-05-06 14:53 EST
SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that